Quéré P, Dardenne M, Bach M A
J Immunol. 1985 Aug;135(2):1180-5.
NZB mice were treated during gestation with thymulin, a thymus-secreted, zinc-associated nonapeptide. Control pregnant NZB mice received either zinc alone or saline alone. Offspring from all three groups of NZB mothers, and age-matched DBA/2 mice, were tested for the following immunologic parameters: thymulin serum levels at 2 and 5 wk of age; splenic anti-sheep red blood cell (anti-SRBC) plaque-forming cell (PFC) numbers after immunization at birth or at 2 wk of age; anti-human gamma-globulin (anti-HGG) antibody titers after immunization at 2 wk of age, with or without prior tolerance induction at birth with deaggregated HGG; spontaneous IgM serum levels at 2 and 5 wk of age; spontaneous splenic anti-trinitrophenyl (anti-TNP) PFC numbers at 2 wk of age. As compared with DBA/2 mice, young NZB mice exhibited low circulating thymulin titers, high antibody responses to SRBC and to HGG, resistance to tolerance induction by deaggregated HGG, increased spontaneous IgM serum levels, and increased spontaneous anti-TNP PFC numbers. However, marked reductions in anti-SRBC and anti-HGG antibody production, both thymus-dependent responses, were observed in the young NZB offspring of thymulin-treated mothers as compared with NZB controls born from zinc- or saline-treated mothers. A delay in the postnatal decrease of serum thymulin levels was also noted in the offspring of thymulin-treated mothers. Interestingly, these effects of in utero thymulin treatment tended to become more pronounced with advancing age during the postnatal period. Conversely, IgM serum levels, spontaneous anti-TNP PFC and sensitivity to tolerance induction were not affected by thymulin treatment during fetal life. Taken together, the data suggest that in utero exposure to pharmacologic concentrations of thymulin induces a persistent and selective improvement of some thymus and T cell dysfunctions but has no effect on intrinsic B cell abnormalities of NZB mice.
在妊娠期间,给新西兰黑鼠(NZB)注射胸腺素(一种胸腺分泌的、与锌相关的九肽)进行治疗。对照的怀孕NZB小鼠单独接受锌或单独接受生理盐水。对来自所有三组NZB母亲的后代以及年龄匹配的DBA/2小鼠进行以下免疫学参数检测:2周龄和5周龄时的胸腺素血清水平;出生时或2周龄时免疫后脾抗绵羊红细胞(抗SRBC)空斑形成细胞(PFC)数量;2周龄时免疫后抗人γ球蛋白(抗HGG)抗体滴度,出生时是否用解聚的HGG诱导过耐受性;2周龄和5周龄时的自发IgM血清水平;2周龄时脾自发抗三硝基苯(抗TNP)PFC数量。与DBA/2小鼠相比,年轻的NZB小鼠循环胸腺素滴度较低,对SRBC和HGG的抗体反应较高,对解聚的HGG诱导耐受性有抗性,自发IgM血清水平升高,自发抗TNP PFC数量增加。然而,与锌或生理盐水处理的母亲所生的NZB对照相比,胸腺素处理的母亲所生的年轻NZB后代中,抗SRBC和抗HGG抗体产生均显著减少,这两种都是依赖胸腺的反应。在胸腺素处理的母亲的后代中还注意到血清胸腺素水平在出生后下降延迟。有趣的是,子宫内胸腺素治疗的这些作用在出生后的时期随着年龄增长往往变得更加明显。相反,IgM血清水平、自发抗TNP PFC以及对耐受性诱导的敏感性在胎儿期不受胸腺素治疗的影响。综上所述,数据表明子宫内暴露于药理浓度的胸腺素可诱导某些胸腺和T细胞功能障碍的持续和选择性改善,但对NZB小鼠内在的B细胞异常没有影响。